Gilad Kaplan is the Director of Protein Analytics and Developability for the Biologics Engineering team at AstraZeneca, where they lead R&D efforts in antibody engineering. Previously, Gilad served as an Associate Director and Senior Scientist at AstraZeneca and MedImmune, focusing on novel therapeutics for Immuno-Oncology and metabolic diseases. With a Ph.D. in Cell Research from Tel Aviv University, they have extensive experience in biopharmaceutical R&D, including team leadership and cross-team collaborations. Prior roles include Postdoctoral Fellow at the National Cancer Institute, where they engineered advanced immunotoxins for cancer treatment.
This person is not in the org chart
This person is not in any teams
This person is not in any offices